Yue Zhang Selected Research

3- O- xylopyranosylholosta- 7,9(11),22,24- tetraene- 3,17- diol

4/2009

Development of nobiliside A loaded liposomal formulation using response surface methodology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Zhang Research Topics

Disease

480	Neoplasms (Cancer) 09/2024 - 12/2003
170	Inflammation (Inflammations) 05/2024 - 02/2008
106	Infections 06/2024 - 06/2005
94	Fibrosis (Cirrhosis) 03/2024 - 12/2006
90	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2006
72	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2011
53	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 02/2008
48	Carcinogenesis 01/2024 - 11/2012
47	Hypoxia (Hypoxemia) 03/2024 - 11/2003
42	Colorectal Neoplasms (Colorectal Cancer) 09/2024 - 01/2012
41	Wounds and Injuries (Trauma) 04/2024 - 02/2006
35	COVID-19 03/2024 - 01/2020
35	Body Weight (Weight, Body) 01/2024 - 10/2007
34	Pain (Aches) 02/2024 - 02/2005
33	Hypertension (High Blood Pressure) 05/2024 - 09/2015
33	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2013
30	Atherosclerosis 05/2024 - 03/2015
30	Liver Neoplasms (Liver Cancer) 01/2024 - 09/2013
29	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 11/2014
28	Stomach Neoplasms (Stomach Cancer) 11/2023 - 11/2015
27	Stroke (Strokes) 03/2024 - 04/2014
27	Lung Neoplasms (Lung Cancer) 10/2023 - 11/2012
26	Mitochondrial Diseases (Mitochondrial Disease) 05/2024 - 01/2014
25	Adenocarcinoma 05/2024 - 03/2015
24	Neuroinflammatory Diseases 01/2024 - 10/2018
24	Cognitive Dysfunction 01/2024 - 05/2014
23	Necrosis 12/2024 - 12/2007
23	Ischemia 01/2024 - 01/2011
23	Myocardial Infarction 12/2023 - 01/2009
22	Obesity 04/2024 - 01/2012
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 06/2015
21	Ischemic Stroke 05/2024 - 01/2015
20	Sepsis (Septicemia) 05/2024 - 06/2013
20	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2016
19	Hemorrhage 03/2024 - 04/2011
19	Carcinoma (Carcinomatosis) 03/2024 - 01/2011
18	Heart Failure 03/2024 - 05/2017
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 03/2006
18	Reperfusion Injury 01/2024 - 04/2011
17	Anemia 03/2024 - 08/2014
17	Rheumatoid Arthritis 02/2024 - 09/2017
17	Infarction (Infarctions) 01/2024 - 06/2011
17	Ureteral Obstruction 11/2023 - 10/2007
16	Asthma (Bronchial Asthma) 04/2024 - 02/2008
16	Brain Ischemia (Cerebral Ischemia) 01/2024 - 11/2011
16	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2018 - 07/2006
15	Thrombosis (Thrombus) 03/2024 - 10/2013
15	Pneumonia (Pneumonitis) 03/2024 - 11/2003
15	Adenocarcinoma of Lung 01/2024 - 05/2004
15	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 10/2009
15	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 02/2008
15	Leukemia 01/2022 - 07/2003

Drug/Important Bio-Agent (IBA)

206	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2004
132	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2010
61	CytokinesIBA 04/2024 - 02/2008
59	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2012
56	Messenger RNA (mRNA)IBA 04/2024 - 10/2007
54	RNA (Ribonucleic Acid)IBA 04/2024 - 09/2002
49	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2013
43	Long Noncoding RNAIBA 01/2024 - 05/2014
41	VaccinesIBA 03/2024 - 03/2006
40	LipidsIBA 05/2024 - 12/2013
37	Therapeutic UsesIBA 02/2024 - 12/2009
34	AntigensIBA 05/2024 - 02/2007
34	EnzymesIBA 05/2024 - 11/2006
34	CollagenIBA 04/2024 - 11/2007
34	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 12/2010
30	Peptides (Polypeptides)IBA 01/2024 - 05/2004
29	InflammasomesIBA 03/2024 - 10/2010
29	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2011
27	CarbonIBA 12/2024 - 07/2013
27	Interleukin-6 (Interleukin 6)IBA 03/2024 - 12/2007
27	AntioxidantsIBA 12/2023 - 04/2011
26	Transcription Factors (Transcription Factor)IBA 05/2024 - 12/2011
26	CateninsIBA 11/2023 - 05/2011
25	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2009
25	Phosphotransferases (Kinase)IBA 11/2023 - 11/2012
22	Circular RNAIBA 04/2024 - 01/2015
22	Caspase 3 (Caspase-3)IBA 03/2024 - 12/2014
22	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 04/2011
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 05/2010
21	LigandsIBA 03/2022 - 08/2015
20	AcidsIBA 05/2024 - 11/2015
20	Indicators and Reagents (Reagents)IBA 10/2023 - 10/2011
19	LipopolysaccharidesIBA 01/2024 - 02/2011
18	Blood Glucose (Blood Sugar)IBA 02/2024 - 01/2006
18	Oxygen (Dioxygen)IBA 02/2024 - 07/2011
18	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
18	Small Interfering RNA (siRNA)IBA 10/2023 - 04/2004
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 11/2012
16	Neuroprotective AgentsIBA 01/2024 - 01/2015
15	CholesterolIBA 05/2024 - 08/2017
15	Dinoprostone (PGE2)FDA Link 10/2023 - 03/2010
14	Triglycerides (Triacylglycerol)IBA 12/2024 - 03/2017

Therapy/Procedure

240	Therapeutics 06/2024 - 11/2003
70	Drug Therapy (Chemotherapy) 04/2024 - 02/2008
57	Immunotherapy 09/2024 - 08/2011
25	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2024 - 11/2007
20	Radiotherapy 05/2024 - 01/2011
16	Vagus Nerve Stimulation 04/2023 - 01/2019